This process leads to resistance against the currently available anti-cancer drugs in many different types of cancers (Sharom, 2007; Nanayakkara et al., 2018; Robinson and Tiriveedhi, 2020) Consequently, the development of P-gp inhibitors is gaining much importance in numerous research works. This evidence concerns the gene PGP and cancer.